Literature DB >> 26221394

Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature.

Naoya Ishibashi1, Toshiya Maebayashi1, Takuya Aizawa1, Masakuni Sakaguchi1, Osamu Abe1, Katsuhiro Miura2, Yoshihiro Hatta2, Masahiko Sugitani3.   

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare tumor that usually arises in the skin. Most patients develop skin lesions, which may be isolated and subsequently spread to affect the whole body. The prognosis is poor. Although BPDCN is usually treated by chemotherapy, radiation therapy is used in some cases (e.g., isolated lesions, elderly patients, or patients with comorbidities). The overall therapeutic efficacy and dose of radiation therapy remain unknown. We herein present a case of successful radiation treatment for BPDCN in a 77-year-old Japanese patient and describe the results of the first literature review on BPDCN of the skin initially treated with radiation therapy. The patient developed a raised, tender, pruritic skin lesion on his left forearm and similar multiple disseminated lesions on his right shoulder and precordial region. Histological and immunohistochemical examination of biopsy specimens of the skin lesions on the left forearm and right shoulder established a diagnosis of BPDCN. The other multiple skin lesions were considered to be disseminated BPDCN. The patient declined chemotherapy and instead elected radiation therapy for the lesion on his left forearm (total of 30 Gy). The skin lesion regressed until only pigmentation was present on the forearm, but the untreated lesions rapidly expanded. Although BPDCN of the skin may respond favorably to initial radiation therapy, it tends to recur in the short term. The optimal dose of radiation therapy remains unclear. Our findings provide a baseline for future research.

Entities:  

Keywords:  18F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT); Dendritic cells; radiation; skin neoplasms

Year:  2015        PMID: 26221394      PMCID: PMC4509339     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  A case of cutaneous blastic plasmacytoid dendritic cell neoplasm.

Authors:  Ruzeng Xue; Tieqiang Wu; Huiqing Pan; Youshou Gu; Bin Yang; Yongfeng Chen; Jushi Qiu
Journal:  Acta Derm Venereol       Date:  2010-11       Impact factor: 4.437

2.  Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.

Authors:  Keiko Hashikawa; Daisuke Niino; Shinichiro Yasumoto; Takekuni Nakama; Junichi Kiyasu; Kensaku Sato; Yoshizo Kimura; Masanori Takeuchi; Yasuo Sugita; Takashi Hashimoto; Koichi Ohshima
Journal:  J Am Acad Dermatol       Date:  2011-08-11       Impact factor: 11.527

3.  Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

Authors:  Arthur E Frankel; Jung H Woo; Chul Ahn; Naveen Pemmaraju; Bruno C Medeiros; Hetty E Carraway; Olga Frankfurt; Stephen J Forman; Xuezhong A Yang; Marina Konopleva; Francine Garnache-Ottou; Fanny Angelot-Delettre; Christopher Brooks; Michael Szarek; Eric Rowinsky
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

4.  Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

Authors:  S Dalle; M Beylot-Barry; M Bagot; D Lipsker; L Machet; P Joly; A Dompmartin; M d'Incan; E Maubec; F Grange; O Dereure; S Prey; S Barete; M Wetterwald; S Fraitag; T Petrella
Journal:  Br J Dermatol       Date:  2009-06-22       Impact factor: 9.302

Review 5.  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary.

Authors:  A Pileri; C Delfino; V Grandi; C Agostinelli; S A Pileri; N Pimpinelli
Journal:  G Ital Dermatol Venereol       Date:  2012-12       Impact factor: 2.011

6.  Bilateral conjunctival lesions in blastic plasmacytoid dendritic cell neoplasm.

Authors:  Toshihiko Matsuo; Kouichi Ichimura; Takehiro Tanaka; Shin Morizane; Keiji Iwatsuki; Motoharu Eguchi; Tadashi Yoshino
Journal:  J Clin Exp Hematop       Date:  2011

7.  Blastic plasmacytoid dendritic cell neoplasm presenting as a subcutaneous mass in an 8-year-old boy.

Authors:  David Nizza; Stephen F Simoneaux
Journal:  Pediatr Radiol       Date:  2010-06-16

8.  CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.

Authors:  M W Bekkenk; P M Jansen; C J L M Meijer; R Willemze
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976

9.  CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.

Authors:  Monika E Pilichowska; Mark D Fleming; Jack L Pinkus; Geraldine S Pinkus
Journal:  Am J Clin Pathol       Date:  2007-09       Impact factor: 2.493

10.  Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

Authors:  Nikolaos J Tsagarakis; Nektaria A Kentrou; Konstantinos A Papadimitriou; Maria Pagoni; Garyfallia Kokkini; Helen Papadaki; Vassiliki Pappa; Theodoros Marinakis; Nikolaos I Anagnostopoulos; Chrissanthi Vadikolia; Achilleas Anagnostopoulos; Maria K Angelopoulou; Evangelos Terpos; Christos Poziopoulos; Konstantinos Anargyrou; Dimitra Rontogianni; Theodora Papadaki; Aikaterini Psarra; Flora N Kontopidou; Dimitra Skoumi; Stefanos I Papadhimitriou; Georgios Paterakis
Journal:  Leuk Res       Date:  2009-09-29       Impact factor: 3.156

View more
  7 in total

Review 1.  Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Authors:  Minas P Economides; David Rizzieri; Naveen Pemmaraju
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 2.  Treatment of blastic plasmacytoid dendritic cell neoplasm.

Authors:  Jill M Sullivan; David A Rizzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 3.  Blastic plasmacytoid dendritic cell neoplasm of the breast: A case report and review of the literature.

Authors:  Hyo-Jae Lee; Hye Mi Park; So Yeon Ki; Yoo-Duk Choi; Sook Jung Yun; Hyo Soon Lim
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

4.  A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report.

Authors:  Fateme Salemi; Seyed Mohammad Reza Mortazavizadeh; Farid Kosari; Seyed Sina Naghibi Irvani; Seyyedmohammadsadeq Mirmoeeni; Amirhossein Azari Jafari
Journal:  J Med Case Rep       Date:  2021-05-23

5.  Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.

Authors:  Naveen Pemmaraju; Nathaniel R Wilson; Guillermo Garcia-Manero; Koji Sasaki; Joseph D Khoury; Nitin Jain; Gautam Borthakur; Farhad Ravandi; Naval Daver; Tapan Kadia; Courtney DiNardo; Elias Jabbour; Sherry Pierce; Muzaffar Qazilbash; Marina Konopleva; Hagop Kantarjian
Journal:  Blood Adv       Date:  2022-05-24

6.  CT findings associated with blastic plasmacytoid dendritic cell neoplasm: a case report.

Authors:  Daniel Jeong; Jung W Choi; Katherine Jeong; Lubomir Sokol
Journal:  Acta Radiol Open       Date:  2016-07-26

Review 7.  Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms.

Authors:  Agnieszka Owczarczyk-Saczonek; Małgorzata Sokołowska-Wojdyło; Berenika Olszewska; Marta Malek; Aleksandra Znajewska-Pander; Anna Kowalczyk; Wojciech Biernat; Grażyna Poniatowska-Broniek; Wanda Knopińska-Posłuszny; Zygmunt Kozielec; Roman Nowicki; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.